Used as an intermediate in the synthesis of pharmaceuticals, particularly in the development of central nervous system agents. It serves as a building block in the production of selective adrenergic receptor modulators. Commonly applied in research settings for the preparation of bioactive molecules and analogs targeting neurological disorders. The trifluoromethoxy substituent enhances lipophilicity, aiding in cell membrane permeability and improving target specificity for potential reduced side effects. Also utilized in synthesis due to its amine functionality, enabling the construction of complex drug candidates.